Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease
Md. Ezazul Haque, In‐Su Kim, Md. Jakaria, et al.
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms
Md. Jakaria, Shofiul Azam, Md. Ezazul Haque, et al.
Redox Biology (2019) Vol. 24, pp. 101223-101223
Open Access | Times Cited: 229
Curcumin’s Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Bahare Salehi, Daniela Călina, Anca Oana Docea, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 430-430
Open Access | Times Cited: 162
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Xiaohang Qian, Xiaoxuan Song, Xiaoli Liu, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101317-101317
Closed Access | Times Cited: 119
Retinal changes in Alzheimer's disease— integrated prospects of imaging, functional and molecular advances
Veer Bala Gupta, Nitin Chitranshi, Jurre den Haan, et al.
Progress in Retinal and Eye Research (2020) Vol. 82, pp. 100899-100899
Open Access | Times Cited: 115
G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits
Shofiul Azam, Md. Ezazul Haque, Md. Jakaria, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 506-506
Open Access | Times Cited: 99
The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
Teresa R. Kee, Sophia Khan, Maya B. Neidhart, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 129-141
Open Access | Times Cited: 11
Chemogenetic modulation of astrocytes and microglia: State‐of‐the‐art and implications in neuroscience
Jo Bossuyt, Yana Van Den Herrewegen, Liam Nestor, et al.
Glia (2023) Vol. 71, Iss. 9, pp. 2071-2095
Open Access | Times Cited: 21
Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease
Yunguang Qiu, Yuan Hou, Dhruv Gohel, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114128-114128
Open Access | Times Cited: 6
Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology
Kavita Sharma, Samjhana Pradhan, Lawrence K. Duffy, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12987-12987
Open Access | Times Cited: 36
The functional role of locus coeruleus microglia in the female stress response
Cora E. Smiley, Brittany S. Pate, Samantha J. Bouknight, et al.
Molecular Psychiatry (2025)
Open Access
Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases
Lu Huang, Ding‐Qiao Xu, Yan‐Yan Chen, et al.
Brain and Behavior (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 34
The Methanol Extract of Allium cepa L. Protects Inflammatory Markers in LPS-Induced BV-2 Microglial Cells and Upregulates the Antiapoptotic Gene and Antioxidant Enzymes in N27-A Cells
Md. Jakaria, Shofiul Azam, Duk-Yeon Cho, et al.
Antioxidants (2019) Vol. 8, Iss. 9, pp. 348-348
Open Access | Times Cited: 35
Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Xinyue Zhang, Dan Wang, Bo Zhang, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 1074-1085
Closed Access | Times Cited: 31
Adenosine receptor signalling in Alzheimer’s disease
Phuc N. H. Trinh, Jo‐Anne Baltos, Shane D. Hellyer, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 3, pp. 359-381
Open Access | Times Cited: 18
Opioid receptor activation suppresses the neuroinflammatory response by promoting microglial M2 polarization
Akash Mali, Jiřı́ Novotný
Molecular and Cellular Neuroscience (2022) Vol. 121, pp. 103744-103744
Closed Access | Times Cited: 17
Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice
Paula de Oliveira, Claire V. Cella, Nicolas Locker, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 16, pp. 3494-3509
Open Access | Times Cited: 15
Reduction in GABAB on glia induce Alzheimer’s disease related changes
Amanda M. Leisgang Osse, Ravi S. Pandey, Ryan A. Wirt, et al.
Brain Behavior and Immunity (2023) Vol. 110, pp. 260-275
Closed Access | Times Cited: 8
Circulating extracellular vesicle-containing microRNAs reveal potential pathogenesis of Alzheimer’s disease
Yi Wang, Ping Yuan, Lu Ding, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 13
Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders
Anna Aleksandra Kaszyńska
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 813-813
Open Access | Times Cited: 2
Lysophosphatidylinositol, an Endogenous Ligand for G Protein-Coupled Receptor 55, Has Anti-inflammatory Effects in Cultured Microglia
Tomoki Minamihata, Katsura Takano, Mitsuaki Moriyama, et al.
Inflammation (2020) Vol. 43, Iss. 5, pp. 1971-1987
Closed Access | Times Cited: 19
Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model
Jackie K. Y. Lau, Min Tian, Yang Shen, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Chemogenetic manipulation of CX3CR1+ cells transiently induces hypolocomotion independent of microglia
Shunyi Zhao, Jiaying Zheng, Lingxiao Wang, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2857-2871
Open Access | Times Cited: 6
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease
Rebecca Ferrisi, Francesca Gado, Caterina Ricardi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7201-7201
Open Access | Times Cited: 5
Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw,Ind Alzheimer’s Disease Model
Alejandro Lillo, Iu Raïch, Jaume Lillo, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 214-214
Open Access | Times Cited: 8
Biological evidence of gintonin efficacy in memory disorders
Md. Jakaria, Shofiul Azam, Eun-Ae Go, et al.
Pharmacological Research (2020) Vol. 163, pp. 105221-105221
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top